DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs

Molecular Pharmacology

Volumn 65, Issue 6, 2004, Pages 1496-1506

  Beljanski, Vladimir ^a   Marzilli, Luigi G ^a,c   Doetsch, Paul W ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CHLORMETHINE; CISPLATIN; MITOMYCIN;

ARTICLE; CELL CYCLE; CYTOTOXICITY; DNA ADDUCT; DNA CROSS LINKING; DNA DAMAGE; DNA RECOMBINATION; EUKARYOTE; EXCISION REPAIR; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; CARMUSTINE; CELL CYCLE; CISPLATIN; CROSS-LINKING REAGENTS; DNA; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; MITOMYCIN; MUTATION; NITROGEN MUSTARD COMPOUNDS; YEASTS;

EID: 2442646433     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.6.1496     Document Type: Article

References (31)

1. Berenbaum MC (1978) A method for testing for synergy with any number of agents. J Infect Dis 137:122-130.
2. Britten RA, Kuny S, and Perdue S (1999) Modification of non-conservative double-strand break (DSB) rejoining activity after the induction of cisplatin resistance in human tumour cells. Br J Cancer 79:843-849.
3. Chou TC and Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27-55.
4. Doetsch PW, Morey NJ, Swanson RL, and Jinks-Robertson S (2001) Yeast base excision repair: interconnections and networks. Prog Nucleic Acid Res Mol Biol 68:29-39.
5. Dronkert ML and Kanaar R (2001) Repair of DNA interstrand cross-links. Mutat Res 486:217-247.
6. Durant ST, Morris MM, Illand M, McKay HJ, McCormick C, Hirst GL, Borts RH, and Brown R (1999) Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. Curr Biol 9:51-54.
7. Ferguson LR (1990) Mutagenic and recombinogenic consequences of DNA-repair inhibition during treatment with 1,3-bis(2-chloroethyl) -1-nitrosourea in Saccharomyces cerevisiae. Mutat Res 241:369-377.
8. Friedberg EC, Walker GC, and Siede W (1995) DNA Repair and Mutagenesis, ASM Press, Washington, DC.
9. Grossmann KF, Brown JC, and Moses RE (1999) Cisplatin DNA cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccharomyces cerevisiae. Mutat Res 434:29-39.
10. Grossmann KF, Ward AM, Matkovic ME, Folias AE, and Moses RE (2001) S. cerevisiae has three pathways for DNA interstrand crosslink repair. Mutat Res 487:73-83.
11. Grossmann KF, Ward AM, and Moses RE (2000) Saccharomyces cerevisiae lacking Snm1, Rev3 or Rad51 have a normal S-phase but arrest permanently in G2 after cisplatin treatment. Mutat Res 461:1-13.
12. Hannan MA, Zimmer SG, and Hazle J (1984) Mechanisms of cisplatin (cis-diamminodichloroplatinum 11)-induced cytotoxicity and genotoxicity in yeast. Mutat Res 127:23-30.
13. Harfe BD and Jinks-Robertson S (2000) Mismatch repair proteins and mitotic genome stability. Mutat Res 451:151-167.
14. Jamieson ER and Lippard SJ (1999) Structure, recognition and processing of cisplatin-DNA adducts. Chem Rev 99:2467-2498.
15. Jinks-Robertson S and Petes TD (1993) Experimental determination of rates of concerted evolution. Methods Enzymol 224:631-646.
16. Kartalou M and Essigmann JM (2001) Mechanisms of resistance to cisplatin. Mutat Res 487:23-43.
17. Lawley PD and Phillips DH (1996) DNA adducts from chemotherapeutic agents. Mutat Res 355:13-40.
18. McA'Nulty MM and Lippard SJ (1996) The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat Res 362:75-86.
19. McHugh PJ, Sones WR, and Hartley JA (2000) Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol Cell Biol 20:3425-3433.
20. Memisoglu A and Samson L (2000) Base excision repair in yeast and mammals. Mutat Res 451:39-51.
21. Nelson JR, Lawrence CW, and Hinkle DC (1996) Thymine-thymine dimer bypass by yeast DNA polymerase zeta. Science (Wash DC) 272:1646-1649.
22. Panasci L, Xu ZY, Bello V, and Aloyz R (2002) The role of DNA repair in nitrogen mustard drug resistance. Anticancer Drug 13:211-220.
23. Perego P, Jimenez GS, Gatti L, Howell SB, and Zunino F (2000) Yeast mutants as a model system for identification of determinants of chemosensitivity. Pharmacol Rev 52:477-492.
24. Prakash S and Prakash L (2000) Nucleotide excision repair in yeast. Mutat Res 451:13-24.
25. Pratt WB (1994) Anticancer Drugs, Oxford University Press, New York.
26. Simon JA, Szankasi P, Nguyen DK, Ludlow C, Dunstan HM, Roberts CJ, Jensen EL, Hartwell LH, and Friend SH (2000) Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. Cancer Res 60:328-333.
27. Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R, and Skorski T (2001) BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 8:795-806.
28. Sonoda E, Okada T, Zhaol GY, Tateishi S, Araki K, Yarnaizumi M, Yagi T, Verkaik NS, van Gent DC, Takata M, et al. (2003) Multiple roles of Rev3, the catalytic subunit of pole in maintaining genome stability in vertebrates. EMBO (Eur Mol Biol Organ) J 22:3188-3197.
29. Swanson RL, Morey NJ, Doetsch PW, and Jinks-Robertson S (1999) Overlapping specificities of base excision repair, nucleotide excision repair, recombination and translesion synthesis pathways for DNA base damage in Saccharomyces cerevisiae. Mol Cell Biol 19:2929-2935.
30. Tannock IF and Goldenberg GJ (1998) Drug resistance and experimental chemotherapy, in The Basic Science of Oncology (Tannock IF and Hill RP eds) pp 392-419, Pergamon Press, New York.
31. Tishkoff DX, Boerger AL, Bertrand P, Filosi N, Gaida GM, Kane MF, and Kolodner RD (1997) Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2. Proc Natl Acad Sci USA 94:7487-7492.